Reconsidering lactate disallowance in pancreatic β cells
Trends in Endocrinology & Metabolism · 2024
DOI: 10.1016/j.tem.2024.06.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Endocrinology & Metabolism, 2024. Verfasst von Accalia Fu. Beteiligte Einrichtung: Diabetes Center of Excellence, University of Massachusetts, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts, Worcester…. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Lactic Acid, L-Lactate Dehydrogenase, Insulin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Diabetes Center of Excellence, University of Massachusetts, Worcester, MA, USA; Program in Molecular Medicine, University of Massachusetts, Worcester, MA, USA. Electronic address: accalia.fu1@umassmed.edu.
Zitieren
APA
Fu, A. (2024). Reconsidering lactate disallowance in pancreatic β cells. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2024.06.014
Vancouver
Fu A. Reconsidering lactate disallowance in pancreatic β cells. Trends in Endocrinology & Metabolism. 2024. doi:10.1016/j.tem.2024.06.014
BibTeX
@article{Fu2024,
author = {Fu, Accalia},
title = {Reconsidering lactate disallowance in pancreatic β cells},
journal = {Trends in Endocrinology & Metabolism},
year = {2024},
doi = {10.1016/j.tem.2024.06.014}
}
EUVIMED